Agency for International Development

Description

The United States Agency for International Development (USAID) is seeking applications from qualified U.S. and Non-U.S. organizations to fund a project entitled “Advancing the development and licensure of vaginal rings and innovative systemic methods for prevention of HIV infection in women”. Two to four cooperative agreements are planned under this notice. Eligibility for these awards is not restricted (see Section C of this Notice of Funding Opportunity (NFO) for eligibility requirements).USAID is committed to moving the microbicides field forward through continued development of promising and innovative HIV prevention products for women in high HIV incidence settings. For the purposes of this NFO the term “microbicides” should be considered as broadly referring to different forms of pre- and post-exposure prophylaxis. Applications may, and are encouraged to, address more than one objective, particularly through strategic public or private partnerships that provide synergy through unbiased collaboration for optimal product development across dosage forms and active ingredients. Objective 1: Expedite activities required for licensure and market introduction of a dapivirine ring product and bridging opportunities to progress toward licensure of a next-generation ring product (e.g. 90 days or more). These should coordinate with and build upon past and other ongoing projects. Areas of activities that could contribute to achieve this public purpose are described below. Objective 2: Support development and optimization of systemic microbicide or multipurpose prevention technologies (MPTs) (e.g. products that combine prevention of HIV with prevention of pregnancy).

Who can apply

• Others

Contact

Elton Fortson <br/>Agreement Officer <br/>
efortson@usaid.gov